April 7, 2017
medical technology innovations

Panaxea hosts MedtechMeeting in Amsterdam

On 23rd of march 2017 Panaxea hosted the MedtechMeeting at the ‘Silicon Valley’ of Amsterdam: Science Park. This event was organized by MedtechPartners which serve as the accelerator of the development of medical technology innovations in the process to get from idea to a marketable product. The goal of the […]
February 22, 2017

Panaxea’s Janne Mewes about the importance of aftercare in cancer patients for employers

As the incidence of cancer is rising and more patients survive their disease, the number of people within the population who have a history of cancer is rising. Unfortunately, most cancer survivors experience bothersome late and long-term symptoms, such as fatigue, low physical functioning, low quality of life, depression, anxiety, […]
February 22, 2017

The economics of bringing precision medicine to the clinic

Precision Medicine’s value is undeniable. But what about its financial impact? And how should we assess its value? Read the views of Panaxea co-founder dr. Lotte Steuten, as presented at the 2017 Precision Medicine World Conference in Silicon Valley. This presentation will cover the unsustainable economics at play, reimbursement challenges […]
February 6, 2017

Digital health innovations: assessment of their impact on health and economic outcomes

With the ageing population in Europe, an increase in the number of people with chronic diseases, limited health care budgets and the means to treat patients at low cost is becoming more and more of an issue. Recently, a European blueprint was established with the objective of optimizing health care […]
October 4, 2016

Integrated care: unlocking the mysteries

Mystery is not a word that we often connect with health and care as these are worlds in which we like to deal with the practical and the real. However it often seems that working out how best to successfully co-ordinate the contribution of different professionals, services and agencies is […]
August 25, 2016
Health Economic Modeling

The broader view of health economics

Thermo Fisher is a long time client of Panaxea. This resulted among others in a tailor made health economic model for the Procalcitonin (PCT) test manufactured by Thermo Fisher. Results of this model were published in the Journal of Medical Economics. Recently, a new study was published by De Jong […]
August 23, 2016

The challenges and opportunities of articulating the value of your diagnostics

We added a new white paper about the challenges and opportunities of articulating the value of your diagnostics! Please click here to download this white paper.
June 20, 2016

MAFEIP follow up: Panaxea joins European Innovation Partnership on Active and Healthy Ageing Action Groups

Following an earlier involvement with the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA), Panaxea is now a partner for the 2016-2018 period. EIP on AHA EIP on AHA is a policy initiative that aims to share and scale up innovative solutions to improve active and healthy ageing […]
June 20, 2016

Further research for predictive biomarkers

Lotte Steuten worked along with Anna Miquel-Cases, Valesca Retèl, and Wim van Harten on a paper on decision about design and priority of studies of emerging predictive biomarkers of high-dose alkylating chemotherapy (HDAC) in triple-negative breast cancer (TNBC). The paper was published in Value in Health. The information was gathered by a value-of-information […]